Functional Mitral Regurgitation Clinical Trial
Official title:
Dapagliflozin Effect on FunctiOnal Mitral Regurgitation and Myocardial Fibrosis (DEFORM): a Multicenter Randomized Controlled Trial
The goal of this clinical trial is to learn about the effect of dapagliflozin on reducing the degree of mitral regurgitation and myocardial fibrosis in patients with functional mitral regurgitation (FMR) of more than moderate and left ventricular ejection fraction (LVEF) more than 40%. The main question[s] it aims to answer are: - For FMR patients with EF>40%, whether adding SGLT2 to guideline directed medical therapy (GDMT) can reduce MR degree and myocardial fibrosis, as well as improve patient's cardio-pulmonary function and quality of life is unknown. - For FMR patients with EF>40%, whether adding SGLT2 to GDMT can decelerate the progression of FMR to end-stage heart failure, reduce the demand for percutaneous mitral valve repair and improve the prognosis is unknown. Participants in dapagliflozin arm will add dapagliflozin of 10 mg/d orally for 6 months on the basis of regular GDMT for FMR. Researchers will compare the dapagliflozin arm to the GDMT arm who only accept the regular GDMT to see if the effective regurgitant orifice area was decreased. The primary endpoint was the effective regurgitant orifice area(EROA) change from baseline to 6 months. The secondary endpoints include the cardiac magnetic resonance assessment of myocardial fibrosis, the N-terminal fragment of the pro brain natriuretic peptides(NT-pro BNP), maximal exercise capacity by cardiopulmonary exercise testing, distance in the 6 minutes walking test, Kansas City cardiomyopathy questionnaire and Cardiovascular events.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02520310 -
AVJ-514 Japan Trial
|
N/A | |
Not yet recruiting |
NCT04396379 -
Epicardial Mitral Touch System for Mitral Insufficiency
|
N/A | |
Not yet recruiting |
NCT05566340 -
Treatment of Moderate FMR During AVR
|
||
Completed |
NCT01899573 -
Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function
|
N/A | |
Terminated |
NCT04529928 -
An Initial Evaluation of the Carillon Mitral Contour System for Treatment of Atrial Function Mitral Regurgitation
|
N/A | |
Recruiting |
NCT03706833 -
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
|
N/A | |
Completed |
NCT00800046 -
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
|
N/A | |
Active, not recruiting |
NCT03929913 -
NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study
|
N/A | |
Active, not recruiting |
NCT05988450 -
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
|
N/A | |
Recruiting |
NCT03616678 -
VenTouch OUS Feasibility Study
|
N/A | |
Not yet recruiting |
NCT04679714 -
EXPLORE FMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Functional Mitral Regurgitation
|
N/A | |
Active, not recruiting |
NCT02701972 -
Evaluation of Safety and Efficacy of the BACE™ Device in the Treatment of Functional Mitral Valve Regurgitation [FMR
|
N/A | |
Enrolling by invitation |
NCT04776798 -
Biomechanical Taping on Low Back Pain With Increased Foot Pronation
|
N/A | |
Enrolling by invitation |
NCT05677568 -
The CINCH-FMR Post-Market Registry: Percutaneous Repair in Functional Mitral Regurgitation
|
||
Recruiting |
NCT03433274 -
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
|
N/A | |
Completed |
NCT05865938 -
PASCAL vs. MitralClip for Mitral Valve Transchatheter Edge-to-Edge Repair
|
||
Terminated |
NCT03016975 -
Edwards Cardioband System ACTIVE Pivotal Clinical Trial (ACTIVE)
|
N/A | |
Completed |
NCT02471664 -
Mitral Loop Cerclage(MLC) for Reducing Functional Mitral Regurgitation
|
N/A | |
Active, not recruiting |
NCT02671799 -
Evaluation of the Minimally Invasive VenTouch™ System in the Treatment of Functional Mitral Valve Regurgitation (FMR)
|
N/A | |
Recruiting |
NCT03142152 -
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
|
N/A |